For the year ending 2026-01-31, NAVN had $357,479K increase in cash & cash equivalents over the period. $32,754K in free cash flow.
| Cash Flow | 2026-01-31 |
|---|---|
| Net loss | -398,030 |
| Stock-based compensation, net of amounts capitalized | 182,089 |
| Non-cash interest expense | 25,724 |
| Deferred income taxes | -11,306 |
| Depreciation and amortization | 60,247 |
| Amortization of contract acquisition costs | 6,298 |
| Provision for doubtful accounts | 9,084 |
| Loss (gain) on fair value adjustments | -47,041 |
| Debt issuance costs expensed related to safes | 2,913 |
| Loss on extinguishment of debt | -117,978 |
| Other | 900 |
| Accounts receivable | 26,031 |
| Prepaid expenses and other current assets | 17,712 |
| Contract acquisition costs | 23,972 |
| Other non-current assets | -20 |
| Accounts payable | 3,082 |
| Accrued expenses and other current liabilities | 45,896 |
| Deferred revenue | 9,992 |
| Operating lease right-of-use asset and operating lease liabilities, net | -383 |
| Other non-current liabilities | 1,641 |
| Net cash provided by (used in) operating activities | 33,671 |
| Capitalized software development costs | 17,990 |
| Purchases of property and equipment | 917 |
| Purchases of investments | 156,290 |
| (increase) decrease in corporate card receivables | -27,481 |
| Cash consideration for business acquisition, net of cash acquired | 0 |
| Other | 354 |
| Net cash (used in) provided by investing activities | -203,032 |
| Proceeds from stock option exercises | 23,893 |
| Proceeds from borrowings of debt | 216,482 |
| Proceeds from issuance of safes | 155,000 |
| Payments of borrowings of debt | 550,511 |
| Payments for debt issuance costs | 11,151 |
| Payments of deferred offering costs | 8,795 |
| Payment of deferred consideration in business combinations | 712 |
| Proceeds from issuance of common stock in ipo, net of underwriting costs | 713,302 |
| Taxes collected from selling shareholders stock option exercises | 15,556 |
| Taxes remitted for selling shareholders stock option exercises | 15,527 |
| Payment of tax withholdings on settlement of rsus | 17,728 |
| Proceeds from exercise of warrants | 110 |
| Net cash provided by financing activities | 519,919 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | 6,921 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | 357,479 |
| Cash, cash equivalents and restricted cash, beginning of period | 310,595 |
| Cash, cash equivalents and restricted cash, end of period | 668,074 |